[#item_full_content] The company is warning that the Curaleaf bid is inadequate, undervalues Aurora, and puts shareholder value and future upside at risk.
Read More
[#item_full_content] The company is warning that the Curaleaf bid is inadequate, undervalues Aurora, and puts shareholder value and future upside at risk.
Read More